S&P 500 7,642.26 −0.28%
Nasdaq 26,023.84 +0.06%
S&P/TSX 35,815.08 −0.44%
Apple 347.08 −0.33%
Nvidia 211.92 −0.14%
Microsoft 524.04 +0.57%
Shopify 236.22 −0.08%
Royal Bank 280.81 −0.70%
CAD/USD 0.7143 +0.30%
LIVE · 12:25 ET
Market ClerkRecap
Fri Oct 23 · markets open6 signals today103 insider buys this week · $208.8MCIRO short report next: Oct 31The week ahead

AKBA

Akebia Therapeutics, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
0.56
−0.02 −3.93%
USD · close Oct 22

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $155.7MP/E —DIV YIELD —FCF YIELD 25.85%REV TTM $219.1M +7.5%NET INCOME −$29.7MNET CASH $106M52W 0.56 – 3.17SEC XBRL · TTM TO Invalid Date

What AKBA had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Oct 14Officer or director changeOct 7open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch AKBA. Know when insiders buy.
One email the day a filing lands. Free.